Effects of a Novel Machine Learning Mobile App on Diet Adherence in Individuals Following the Low Fodmap Diet
Completed · Not applicable
Conditions studied: IBS - Irritable Bowel Syndrome
In brief
A high fermented, oligio-, di-, monosaccharide, and polyols (FODMAP) diet has been shown to exacerbate the symptoms of irritable bowel syndrome (IBS). Previous literature has shown significant improvement in IBS symptoms after adherence to a low FODMAP diet (LFD); hence, LFD is a viable treatment method for IBS and IBS-like symptoms. However, adherence to the LFD has proven to be difficult with participants stating that information provided by medical practitioners is generalized and nonspecific requiring them to search for supplementary information to fit their individual needs. Notably, studies that have used a combination of online and in-person methods for treatment have shown improved adherence to the LFD. The purpose of this study is to determine whether a novel machine learning dietary mobile application (ML-App) will improve adherence to the LFD compared to a standard online dietary intervention in populations with IBS or IBS-like symptoms over a 4 week period.
Key facts
- Study ID
- NCT04256551
- Run by
- Arizona State University
- People needed
- 58
- Starts
- 2020-01-23
- Expected to finish
- 2020-06-01
- Last updated by the study team
- 2020-07-08
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- IBS-SSS score ≥ 175 (moderate to severe IBS)
- meet the Rome IV criteria for IBS of any type including those with IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), IBS mixed typed (IBS-M), or IBS unsubtyped (IBS-U), and had symptoms for the past 3 months or greater
- own an I-phone
- have not used a dietary application or elimination diet for IBS in the past 6 months
- must be willing to participate in the low FODMAP diet intervention over a 4-week period with a monitoring period of 2-weeks
- agree to complete online questionnaires as frequently as once per week from study start.
You may not qualify if…
- individuals with food allergies (not food intolerances)
- smokers
- those with history of chronic disease (other than gastrointestinal dysfunction)
- nutrition student or professional
- prescription medication is permitted unless the medication is to treat IBS (which includes steroids).
Where it is running
- Arizona State University — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.